SS-31peptidereview The quest for enhanced cellular function and the mitigation of age-related decline has led to significant interest in novel therapeutic agents. Among these, the SA-31 peptide, also widely recognized as elamipretide, Bendavia, and MTP-131, has emerged as a compelling subject of scientific inquiry2025年12月15日—SS-31, which belongs to a family of mitochondrion-targeted peptide antioxidants, was shown to reduce mitochondrial reactive oxygen species .... This mitochondria-targeted peptide is a synthetic, cell-permeable tetrapeptide with a unique mechanism of action that focuses on bolstering the health and efficiency of mitochondria, the powerhouses of our cells. Research indicates that SA-31 peptide has shown a compelling amount of promise in slowing or mitigating aging-related changes by directly addressing mitochondrial dysfunction.
At its core, SA-31 peptide is a cell-permeable aromatic cationic tetrapeptide with a molecular weight of approximately 639.8 g/mol. Its specific amino acid sequence, often represented as D-Arg-2',6'-dimethyltyrosine-Lys-Phe-NH2, allows it to interact intimately with cellular structures. A key aspect of its mechanism involves its selective accumulation within mitochondria, particularly targeting the inner mitochondrial membrane. Here, it binds to cardiolipin, a crucial phospholipid integral to mitochondrial structure and function.[Retracted] Mitochondrial‐Targeted Antioxidant Peptide ... This interaction is believed to be fundamental to its protective and restorative effects作者:MT Sweetwyne·2017·被引用次数:112—A short course ofSS-31 has protective benefits on glomerular mitochondria, accompanied by temporal changes to the glomerular architecture..
One of the primary benefits of SA-31 peptide lies in its ability to improve mitochondrial function. It achieves this by enhancing electron transfer through cytochrome c, a critical component of the electron transport chain. This, in turn, leads to improved oxidative phosphorylation coupling and increased adenosine triphosphate (ATP) synthesis, the primary energy currency of the cellMitochondria-targeted peptide SS-31 attenuates renal .... By optimizing energy production, SA-31 peptide can help counteract age-related declines in cellular energy output, a phenomenon often linked to fatigue and reduced physiological performance. Furthermore, research suggests that SA-31 peptide can reverse mitochondrial dysfunction and ameliorate conditions in various disease models.Improving mitochondrial function with SS-31 reverses age ...
Beyond energy production, SA-31 peptide exhibits significant antioxidant properties. It acts as a scavenger of reactive oxygen species (ROS), often referred to as free radicals. ROS are byproducts of normal cellular metabolism, but excessive accumulation can lead to oxidative stress, damaging cellular components like DNA, proteins, and lipids. By reducing mitochondrial ROS, SA-31 peptide promotes cellular resilience and protects against the damaging effects of oxidative stress.作者:MT Sweetwyne·2017·被引用次数:112—SS-31 enhances electron transfer through cytochrome cto improve oxidative phosphorylation coupling, increases adenosine triphosphate synthesis, and reduces ROS ... This mitochondrial targeted peptide is therefore instrumental in safeguarding cells from damage, particularly in conditions where oxidative stress is a contributing factor. Studies have shown that SA-31 has protective benefits on glomerular mitochondria, suggesting its potential in renal health.SS-31(also known as Bendavia, Elamipretide, and MTP-131) is a smallpeptidethat accumulates in mitochondria and scavenges reactive oxygen species.
The therapeutic potential of SA-31 peptide extends to various physiological systems and conditions.SS-31 (Elamipretide)is designed to support cellular resilience at the source. By targeting mitochondrial efficiency directly, it helps strengthen energy ... Its ability to restore mitochondrial health and protect cells from damage makes it a candidate for addressing a range of age-related ailments and diseases characterized by mitochondrial dysfunction. For instance, research has explored its role in:
* Kidney Health: Mitochondrion-Targeted Peptide SS-31 has demonstrated a protective effect against kidney injury induced by high glucose levels, a critical factor in diabetic nephropathy. This indicates a potential for SA-31 peptide kidney applications in managing or preventing kidney damage.
* Cardiovascular Health: Studies have investigated the mitochondrial-targeted peptide SS-31's role in preventing atherosclerotic development, suggesting its potential in cardiovascular disease management.
* Neurological Function: SA-31 is reported to protect against mitochondrial dysfunction, attenuate oxidative stress, and the inflammatory response in the hippocampus, which could have implications for cognitive health and neurodegenerative diseases.
* Skeletal Muscle Energetics: The mitochondrial targeted peptide SS-31 has been shown to improve skeletal muscle energetics and exercise capacity by directly targeting age-related mitochondrial dysfunction. This has led to interest in SA-31 peptide bodybuilding applications for enhancing athletic performance and recovery.
* Ocular Health: SS31 promotes resilience of RPE cells to oxidative stress by stabilizing mitochondrial function, suggesting potential benefits for retinal health.
* Barth Syndrome: Notably, elamipretide is a medication used for the treatment of Barth syndrome, a rare genetic disorder characterized by severe mitochondrial abnormalities. This highlights the established therapeutic relevance of this peptide.[Retracted] Mitochondrial‐Targeted Antioxidant Peptide ...
The Szeto-Schiller peptide SS-31 is a subject of ongoing research, with various studies exploring its efficacy and safety across different contexts. While the exact SA-31 peptide half-life and optimal SA-31 peptide dosage are subjects of clinical investigation and may vary depending on the specific application and formulation, the peptide is generally described as pharmaceutical-grade.2025年9月16日—One peptide in particular, called SS-31,has shown a compelling amount of promise in slowing or mitigating aging-related changes. What's more, ... Understanding SA-31 peptide review information and potential SA-31 peptide side effects is crucial for individuals considering its use.
In summary, the SA-31 peptide represents a significant advancement in our understanding of mitochondrial health and cellular aging. Its capacity to target mitochondria directly, enhance energy production, and combat oxidative stress positions it as a promising therapeutic agent with broad applications. As research continues to unveil the full potential of this unique tetrapeptide, its role in promoting cellular resilience and mitigating age-related decline is becoming increasingly clear作者:Y Hou·2016·被引用次数:137—This study demonstrates a protective effect of SS-31against HG-induced renal injury via an antioxidant mechanism in diabetic nephropathy.. The pharmaceutical-grade mitochondria-targeting peptide is designed to protect against oxidative stress, restore cellular energy production, and ultimately support overall cellular vitality.
Join the newsletter to receive news, updates, new products and freebies in your inbox.